Aspira Women's Health Inc.
AWH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.3% | 11.9% | 20.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.7% | 57.5% | 52.8% | 45% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -176.3% | -180.2% | -377.2% | -474.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -142.6% | -182.3% | -365.2% | -465.5% |
| EPS Diluted | -0.93 | -1.81 | -3.85 | -4.28 |
| % Growth | 48.6% | 53% | 10% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |